Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors

Bone Marrow Transplantation

Volumn 51, Issue 3, 2016, Pages 428-431

  Lindemann, M ^a   Koldehoff, M ^a   Fiedler, M ^a   Schumann, A ^a   Ottinger, H D ^a   Heinemann, F M ^a   Roggendorf, M ^a   Horn, P A ^a   Beelen, D W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANTIBODY TITER; CACHEXIA; CASE REPORT; CELLULAR IMMUNITY; CHEMOTHERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; DONOR; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HUMAN; HUMORAL IMMUNITY; INFECTION CONTROL; LETTER; LOW DRUG DOSE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; VACCINATION; VIRUS REACTIVATION; HEPATITIS B VIRUS;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; TISSUE DONORS; VACCINATION;

EID: 84959519896     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.253     Document Type: Letter

References (15)

1. Onozawa M, Hashino S, Izumiyama K, Kahata K, Chuma M, Mori A et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 2005; 79: 616-619.
2. Knöll A, Boehm S, Hahn J, Holler E, Jilg W. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat 2007; 14: 478-483.
3. Idilman R, Ustun C, Karayalcin S, Aktemel A, Turkyilmaz AR, Ozcan M et al. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant 2003; 17: 438-443.
4. Harris AE, Styczynski J, Bodge M, Mohty M, Savani BN, Ljungman P. Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?. Bone Marrow Transplant 2015; 50: 899-903.
5. Ilan Y, Nagler A, Adler R, Naparstek E, Or R, Slavin S et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology 1993; 18: 246-252.
6. Ilan Y, Nagler A, Shouval D, Ackerstein A, Or R, Kapelushnik J et al. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors. Clin Exp Immunol 1994; 97: 299-302.
7. Ilan Y, Nagler A, Zeira E, Adler R, Slavin S, Shouval D. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Bone Marrow Transplant 2000; 26: 633-638.
8. Lindemann M, Barsegian V, Runde V, Fiedler M, Heermann KH, Schaefer UW et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation 2003; 75: 833-838.
9. Wimperis JZ, Brenner MK, Prentice HG, Reittie JE, Karayiannis P, Griffiths PD et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; 1: 339-343.
10. Storek J, Dawson MA, Lim LC, Burman BE, Stevens-Ayers T, Viganego F et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337-346.
11. Schumann A, Fiedler M, Dahmen U, Grosse-Wilde H, Roggendorf M, Lindemann M. Cellular and humoral immune response to a third generation hepatitis B vaccine. J Viral Hepat 2007; 14: 592-598.
12. Lindemann M, Barsegian V, Siffert W, Ferencik S, Roggendorf M, Grosse-Wilde H. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination. Virology 2002; 297: 245-252.
13. Schumann A, Lindemann M, Valentin-Gamazo C, Lu M, Elmaagacli A, Dahmen U et al. Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation 2009; 87: 103-111.
14. Shouval D, Roggendorf H, Roggendorf M. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine. Med Microbiol Immunol 2015; 204: 57-68.
15. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.